SPOTLIGHT -
Slideshow
Author(s):
A meta-analysis exploring factors associated with quality of life in first-episode psychosis provides guidance and take-home points for clinicians.
Marking Progress, Promise of Prescription Digital Therapeutics for Mental Health: Interview with Shaheen Lakhan, MD, PhD
Treating ‘Morally Objectionable’ Patients
FDA Officially Eliminates Clozapine REMS
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists
Positive Phase 2 Results on NBI-1117568 for Schizophrenia Presented at 2025 ASCP Annual Meeting